Sonali Smith to Lymphoma, Non-Hodgkin
This is a "connection" page, showing publications Sonali Smith has written about Lymphoma, Non-Hodgkin.
Connection Strength
2.880
-
Too much and not enough: revisiting maintenance rituximab in indolent lymphomas. Haematologica. 2022 02 01; 107(2):353-354.
Score: 0.683
-
Indolent lymphomas: introduction to a series highlighting progress and ongoing challenges. Haematologica. 2022 01 01; 107(1):4-6.
Score: 0.679
-
New drugs for the treatment of non-Hodgkin lymphomas. Chin Clin Oncol. 2015 Mar; 4(1):14.
Score: 0.422
-
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium. J Clin Oncol. 2010 Nov 01; 28(31):4740-6.
Score: 0.310
-
Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B. Br J Haematol. 2008 Feb; 140(3):313-9.
Score: 0.259
-
Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906. Leuk Lymphoma. 2006 Aug; 47(8):1511-7.
Score: 0.233
-
Something old, something new.... Leuk Lymphoma. 2006 Apr; 47(4):576-7.
Score: 0.228
-
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant. Biol Blood Marrow Transplant. 2008 Aug; 14(8):904-12.
Score: 0.067